The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasis. (Q37722744)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Richard B. Warren

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Alan Menter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

Molecular Diagnosis and Therapy

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

81-93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03256357

29 January 2020

exact match

0 references

cites work

Pathogenesis and clinical features of psoriasis

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Psoriasis causes as much disability as other major medical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Pharmacogenetics and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Genomic-scale analysis of psoriatic skin reveals differentially expressed insulin-like growth factor-binding protein-7 after phototherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Role of caveolin 1, E-cadherin, Enolase 2 and PKCalpha on resistance to methotrexate in human HT29 colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Genetic contribution to variable human CYP3A-mediated metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

MDR-1 C3435T polymorphism influences cyclosporine a dose requirement in liver-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Alefacept therapy produces remission for patients with chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell counts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Expression of tolerance associated gene-1, a mitochondrial protein inhibiting T cell activation, can be used to predict response to immune modulating therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Polymorphism at position -308 of the tumour necrosis factor alpha gene and rheumatoid arthritis pharmacogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Long-term prognosis in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Induction of vitamin D receptor mRNA expression in psoriatic plaques correlates with clinical response to 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Vitamin D and systemic cancer: is this relevant to malignant melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Transcriptional regulation of Th1/Th2 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Vitamin D receptor genotypes are not associated with clinical response to calcipotriol in Korean psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Fine Mapping of the Psoriasis Susceptibility Gene PSORS1: A Reassessment of Risk Associated with a Putative Risk Haplotype Lacking HLA-Cw6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Association of TNF -238 and -308 Promoter Polymorphisms with Psoriasis Vulgaris and Psoriatic Arthritis but not with Pustulosis Palmoplantaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Polymorphisms in Folate, Pyrimidine, and Purine Metabolism Are Associated with Efficacy and Toxicity of Methotrexate in Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256357

Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis

21 January 2018

1 reference

12 December 2020

Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patients

1 reference

12 December 2020

A distinct inflammatory gene expression profile in patients with psoriatic arthritis

1 reference

12 December 2020

Vitamin D Receptor Polymorphism and Calcipotriol Response in Patients with Psoriasis

1 reference

12 December 2020

The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients

1 reference

12 December 2020

Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol

1 reference

12 December 2020

A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma.

1 reference

12 December 2020

Single nucleotide polymorphisms of VEGF gene and Psoriasis risk

1 reference

12 December 2020

Single-nucleotide polymorphisms and haplotypes in the VEGF receptor 3 gene and the haplotype GC in the VEGFA gene are associated with psoriasis in Koreans

1 reference

12 December 2020

Methotrexate revisited: effects of long-term treatment in psoriasis

1 reference

12 December 2020

Molecular differences in anticytokine therapies

1 reference

12 December 2020

Association of patient-reported psoriasis severity with income and employment

1 reference

12 December 2020

Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules.

1 reference

12 December 2020

Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients

1 reference

12 December 2020

Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial

1 reference

12 December 2020

The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients

1 reference

12 December 2020

A novel G/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele

1 reference

12 December 2020

Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis

1 reference

12 December 2020

Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies

1 reference

12 December 2020

Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling

1 reference

12 December 2020

Cyclosporine improves psoriasis in a double-blind study

1 reference

12 December 2020

Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis.

1 reference

12 December 2020

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

1 reference

12 December 2020

Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate

1 reference

12 December 2020

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

12 December 2020

Identification of Cellular Pathways of "Type 1," Th17 T Cells, and TNF- and Inducible Nitric Oxide Synthase-Producing Dendritic Cells in Autoimmune Inflammation through Pharmacogenomic Study of Cyclosporine A in Psoriasis

1 reference

12 December 2020

Prevalence of cardiovascular risk factors in patients with psoriasis

1 reference

12 December 2020

Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

1 reference

12 December 2020

Expression of interleukin-12 is increased in psoriatic skin

1 reference

12 December 2020

Etanercept as monotherapy in patients with psoriasis

1 reference

12 December 2020

Treatment of psoriasis with folic acid antagonists

1 reference

12 December 2020

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

1 reference

12 December 2020

A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity

1 reference

12 December 2020

Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis

1 reference

12 December 2020

Risk of Myocardial Infarction in Patients With Psoriasis

1 reference

12 December 2020

Psoriasis and HLA-Cw6

1 reference

12 December 2020

Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect

1 reference

12 December 2020

Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20359251%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference